# Richard M. Stone

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/richard-m-stone/

## Facts

| Field | Value |
| --- | --- |
| Citations | 77,655 |
| Field | Acute Myeloid Leukemia Research |
| h-index | 133 |
| i10-index | 589 |
| Last Known Institution | National University of Singapore |
| OpenAlex ID | https://openalex.org/A5071023119 |
| ORCID iD | https://orcid.org/0000-0002-7526-2633 |
| Works | 1,846 |

## Researcher papers

- [Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/acute-myeloid-leukemia-version-3-2017-nccn-clinical-practice-guidelines-in/)
- [Granulocyte–Macrophage Colony-Stimulating Factor after Initial Chemotherapy for Elderly Patients with Primary Acute Myelogenous Leukemia](https://scholariq.org/papers/granulocyte-macrophage-colony-stimulating-factor-after-initial-chemotherapy-for/)
- [The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice](https://scholariq.org/papers/the-public-repository-of-xenografts-enables-discovery-and-randomized-phase-ii/)
- [Phase III Randomized Multicenter Study of a Humanized Anti-CD33 Monoclonal Antibody, Lintuzumab, in Combination With Chemotherapy, Versus Chemotherapy Alone in Patients With Refractory or First-Relapsed Acute Myeloid Leukemia](https://scholariq.org/papers/phase-iii-randomized-multicenter-study-of-a-humanized-anti-cd33-monoclonal/)
- [Expression and prognostic impact of lncRNAs in acute myeloid leukemia](https://scholariq.org/papers/expression-and-prognostic-impact-of-lncrnas-in-acute-myeloid-leukemia/)
- [American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults](https://scholariq.org/papers/american-society-of-hematology-2020-guidelines-for-treating-newly-diagnosed/)
- [Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms](https://scholariq.org/papers/phase-i-first-in-human-dose-escalation-study-of-the-oral-sf3b1-modulator-h3b/)
- [Health care utilization and end‐of‐life care for older patients with acute myeloid leukemia](https://scholariq.org/papers/health-care-utilization-and-end-of-life-care-for-older-patients-with-acute/)

## Researcher topics

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

## Researcher university

- [National University of Singapore](https://scholariq.org/institutions/national-university-of-singapore/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.